We evaluated serum sphingolipids in HCV infection and in NAFLD.
Serum acid sphingomyelinase is upregulated in patients with chronic liver disease.
Serum ceramides and dihydroceramides accumulate in NAFLD.
Serum sphingosine levels are elevated in patients with chronic liver disease.